Osteoporosis, PostmenopausalNCT03225703
The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women
A study testing Hopping in people with Osteoporosis, Postmenopausal and Osteoarthritis, Knee, run by Loughborough University at 1 site in United Kingdom.
Trial summary
Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people present with fragility fractures in the UK each year. Read more about this study
- Who is it for?
- Ages 55 to 70 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Osteoporosis, Postmenopausal, Osteoarthritis, Knee, BMD
- What is being tested?
- Hopping
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 32 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jan 2017to Jan 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 70 years
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Post-menopausal - at least 12 months since last menstruation and/or hysterectomy, oophorectomy or hormonal contraceptive use
Who cannot join
- Existing knee, hip or back injury.
- Any medical conditions or injuries which exclude participation in an exercise intervention e.g. heart conditions, hypertension
- BMI > 30 kg/m2
- Participation in a study involving ionising radiation in the previous 12 months.
- Exercise involving ground reaction forces greater than that of jogging more than once a week.
- Contraindications to MRI or DXA
- Osteoporotic (FRAX score requiring the participant is advised to seek treatment)
- Medication affecting bone metabolism or density
Trial locations and contacts
1 site in 1 country.
Christopher M Hartley, MSC contact
United Kingdom1 site, 1 recruiting
- Recruiting
Loughborough University
Loughborough, Leicestershire, LE11 3TU
Christopher M Hartley, MSc, c.hartley@lboro.ac.uk
Katherine Brooke-Wavell, PhD, 01509 222749, k.s.f.brooke-wavell@lboro.ac.uk
About this study
Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people present with fragility fractures in the UK each year. High impact exercise has been shown to improve markers of bone health but the effect of this exercise on the cartilage is less well understood. A six month, one leg, exercise program based on hopping will be carried out by a group of post-menopausal women. Post-menopausal women are particularly at risk from OP and the research should give information on the feasibility of this type of exercise program in this age group and the effect on cartilage. Participants will be aged between 55 and 70 (at least five years post menopause) with no conditions that would limit their ability to complete the exercise program.
To assess changes in participants' cartilage and bone properties they will be asked to attend several meetings at Loughborough University. Before and after the exercise program participants will have bone density scans and MRI scans of the knee joint. A subset (n=4) will undergo high resolution bone scans that can demonstrate changes in bone structure. The intervention is a home based exercise programme lasting approximately 10 minutes per day. Initially this will be individualised to each participant with the end goal being daily exercise sessions. The programme will last for six months with supervised sessions offered throughout the trial. Using an intervention affecting just one leg will allow the research team to use the other leg as a control.
The research team hypothesise that in a population of post-menopausal women, a six month, unilateral exercise intervention will improve bone mineral density at the proximal femur with no negative effects on articular cartilage.
Read the detailed description
The research is a 6 month, intervention study of unilateral (single limb) exercise with the changes in a randomly chosen exercise leg being compared to those in the other (control) leg.
Potential participants (women aged 55-70) will be approached via existing links in the community, at local community centres, through local media, posters and flyers. After initial contact to determine whether they meet the inclusion/exclusion criteria they will be invited to join the study and sent the participant information sheet (PIS). If they then wish to aid in the research they will be invited to a first meeting at Loughborough University.
At the initial meeting the participant can further discuss the project and PIS with the research team. If they fully understand the project and are happy to take part they will be invited to sign the informed consent form. At this stage each participant will be anonymised using a project code. Screening and baseline measurements will then be taken.
Screening questionnaires will be taken following consent to the study. These include a demographic questionnaire, health screen questionnaire, calcium intake questionnaire, physical activity readiness questionnaire (PAR-Q) and bone physical activity questionnaire (BPAQ).
Dual X-ray Absorptiometry (DXA) scans of the whole body, anterior-posterior (AP) spine and dual femur will be taken for each participant to give baseline measurements of bone mineral density.Standard positioning procedures for the measurement being taken will be utilised to allow the calculation of the T-score.
Functional tests will be performed to investigate hopping and balance ability. Unilateral balance will be analysed by measuring postural sway using a force platform. Participants will be asked to balance on one leg for up to 30 seconds. Amplitude of displacement will be calculated, this is the distance between the maximum and minimum centre of pressure (COP) in both directions. COP path length is the total distance travelled and will be calculated and divided by the trial time to give the COP velocity.
Maximal hop height will be measured by recording the vertical displacement of a marker placed on the lumbar spine of each participant whilst conducting a maximal hop. This will be repeated for each leg. The ground reaction force (GRF) of the maximal hop will be recorded using a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform a counter movement, maximal hop using their arms to help with propulsion and ensure maximal hop height. After one or two familiarisation attempts the participant will be asked to complete three maximal hops. Allowing for repeats if they do not land fully on the force platform. The peak GRF recorded from these three attempts will be used in the final analysis.
Ground reaction forces during a set of ten hops, which is the end goal of the exercise programme, will be recorded on a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform ten counter movement hops using their arms to help with propulsion if able. At the baseline measurements participants will be asked to perform ten hops to the best of their ability, with a rigid support available for them to lean on
A second appointment will be arranged to acquire baseline MRI scans of each knee joint. This will involve the safety checks, conversation with the radiographers and scan times of up to one hour.
Following the MRI scans the exercise leg will be randomly assigned using opaque envelopes. Each envelope will contain a note saying either 'left leg' or 'right leg'. The envelopes will be split into smaller subgroups of eight for minimisation. This will remove the possibility of the first half of volunteers choosing the same leg and removing the randomisation effect on the second half. Participants will be presented with a training diary and instructions on how to complete the exercise programme over six months. The first day of exercise will be completed with the research team at this appointment and the intervention considered started. This second meeting should last for approximately 90 minutes.
The required exercise lasts for no longer than 10 minutes each session and can be performed at home. The intervention will be personalised to the individual's ability and the frequency of the exercise will steadily increase as the participant improves, until the exercise is completed daily. Regular group sessions at Loughborough University will be offered to all participants. The exercise time will remain at ten minutes but the session will be longer, allowing for discussion and check-ups with participants. These will be weekly sessions for the first two months and then once a month for the remaining time.
Follow up measurements will take place six months after the commencement of the exercise programme. Repeat DXA, MRI and functional outcome tests will be carried out on all participants, following the same protocol as at baseline. Again this will occur over two meetings at Loughborough University.
A subset (n=4) will undergo high resolution bone scans (HR-pQCT) that can demonstrate changes in bone structure. This measurement will be taken at the distal tibia and lasts around three minutes per leg. Measurements will be taken pre and post the six month exercise intervention.
Descriptive statistics will be calculated to give information on mean values and variation (standard deviation) of the cohort. This will include age, height, body mass, BMI and time since last menstruation.
Using Levene's test when comparing the exercise to control leg and Mauchly's test of sphericity to compare from baseline to end of study, the variance of the data will be analysed. Normal distribution will be analysed using Shapiro-Wilks test and visual examination of Q-Q plot. If variance is shown to be homogenous and distribution normal within the population then a repeated measures analysis of variance (RM-ANOVA)will be used to detect any significant differences between leg (exercise versus control, time (baseline versus post-intervention) or leg x time interaction in the outcome variable described previously. If any of the outcome measures do not meet the assumptions to conduct parametric tests i.e. ANOVA then Kruskal-Wallis H test will be used to detect any significant change in differences.
- Conditions
- Osteoporosis, Postmenopausal, Osteoarthritis, Knee, BMD
- Being tested
- Hopping
- Keywords
- Exercise, Osteoporosis, Osteoarthritis, MRI, DXA, High Impact, Cartilage, Bone
- Medical subject headings
- Osteoporosis, Postmenopausal, Osteoarthritis, Knee, Motor Activity, Osteoporosis, Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
HoppingBehavioural
A unilateral, hopping based exercise programme lasting six months.
| Study group | Role | What they receive |
|---|---|---|
| Exercise Leg | Active comparator | Left or right leg randomly assigned as exercise leg in a unilateral, exercise intervention. This will be a progressive exercise programme with the aim being to complete 50 multidirectional hops completed daily. (Hopping) Receives: Behavioral: Hopping |
| Non exercise Leg | No intervention | Randomly assigned non-exercise, control leg. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in T2 Relaxation Time (ms)
T2 mapping is an indicator of the water content in cartilage, with longer relaxation times a marker of cartilage degeneration
Measured: 6 months (pre and post intervention)
Secondary outcomes (46)
Change in Femoral neck bone mineral density (g/cm2)
Measured: 6 months (pre and post intervention)
Change in Femoral neck bone mineral content (g)
Measured: 6 months (pre and post intervention)
Change in Spine bone mineral density (g/cm2)
Measured: 6 months (pre and post intervention)
Change in Spine bone mineral content (g)
Measured: 6 months (pre and post intervention)
Change in Postural sway (mm)
Measured: 6 months (pre and post intervention)
Change in Maximal hop height (mm)
Measured: 6 months (pre and post intervention)
Change in Ground Reaction force Maximal Hop (N)
Measured: 6 months (pre and post intervention)
Change in Ground Reaction force for a set of ten hops (N)
Measured: 6 months (pre and post intervention)
Change in BMD(D100) (mg HA/cm3)
Volumetric Bone mineral density
Measured: 6 months (pre and post intervention)
Change in Total bone mass (mg)
Measured: 6 months (pre and post intervention)
Change in BV/TV (%)
Percent bone volume
Measured: 6 months (pre and post intervention)
Change in pBV/TV (%)
Plate bone volume fraction
Measured: 6 months (pre and post intervention)
Change in rBV/TV (%)
Rod bone volume fraction
Measured: 6 months (pre and post intervention)
Change in pBV/rBV (%)
Plate to - rod ratio
Measured: 6 months (pre and post intervention)
Change in pBV/BV (%)
Plate tissue fraction
Measured: 6 months (pre and post intervention)
Change in rBV/BV (%)
Rod tissue fraction
Measured: 6 months (pre and post intervention)
Change in Bone surface(BS) (mm2)
Measured: 6 months (pre and post intervention)
Change in BS/TV (mm-1)
Bone surface density
Measured: 6 months (pre and post intervention)
Change in Tb.Th (mm)
Trabecular thickness
Measured: 6 months (pre and post intervention)
Change in Tb.Sp (mm)
Trabecular Separation
Measured: 6 months (pre and post intervention)
Change in Tb.N (mm-1)
Trabecular number
Measured: 6 months (pre and post intervention)
Change in Tb.Pf
Trabecular bone pattern (Tb.PF) follows the course of stress lines in the bone. This measurement indicates where the bone is under increased stress.
Measured: 6 months (pre and post intervention)
Change in Conn.D (mm-3)
Connectivity density
Measured: 6 months (pre and post intervention)
Change in DA
Degree of anisotropy
Measured: 6 months (pre and post intervention)
Change in τ
Tortuosity (τ) is a measure of how well a structure can curve and bend easily. This is an indicator of where the most stress is on the bone structure.
Measured: 6 months (pre and post intervention)
Change in SMI
Structural model index
Measured: 6 months (pre and post intervention)
Change in BRV (mm3)
Bone resorption volume
Measured: 6 months (pre and post intervention)
Change in BFV (mm3)
Bone formation volume
Measured: 6 months (pre and post intervention)
Change in BRM (mg)
Bone resorption mass
Measured: 6 months (pre and post intervention)
Change in BFM (mg)
Bone formation mass
Measured: 6 months (pre and post intervention)
Change in BRF (%)
Bone resorption fraction
Measured: 6 months (pre and post intervention)
Change in BFF(%)
Bone formation fraction
Measured: 6 months (pre and post intervention)
Change in BRR(mm3/week)
Bone resorption rate
Measured: 6 months (pre and post intervention)
Change in BFR(mm3/week)
Bone formation rate
Measured: 6 months (pre and post intervention)
Change in Trabecular orientation distribution (Tb.O.D) (angle in degrees)
This is a measurement of the orientation of the trabeculae in the distal tibia relative to the central axis tibial shaft. The orientation can be categorised into transvers direction and longitudinal direction along the tibial shaft
Measured: 6 months (pre and post intervention)
Change in Ct.Th(mm)
Cortical thickness
Measured: 6 months (pre and post intervention)
Change in B.Po(%)
Bone porosity
Measured: 6 months (pre and post intervention)
Change in Po.Dm(mm)
Pore diameter
Measured: 6 months (pre and post intervention)
Change in Pore volume distribution
Measured: 6 months (pre and post intervention)
Change in Failure load (N)
Measured: 6 months (pre and post intervention)
Change in Strain
This analyses the change in length of the bone over the time period, expressed as % change.
Measured: 6 months (pre and post intervention)
Change in Stiffness (N/mm)
Measured: 6 months (pre and post intervention)
Change in Young's Modulus (GPa)
Measured: 6 months (pre and post intervention)
Change in Mechanical anisotropic ratio
Measured: 6 months (pre and post intervention)
Change in Strain energy density (J/m3)
Measured: 6 months (pre and post intervention)
Change in Strain gradient (με/mm)
Measured: 6 months (pre and post intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jul 2017
- Study startJan 2017
- Primary completionJun 2018 (estimated)
- Study completionJan 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Osteoporosis, PostmenopausalStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Participants will complete a unilateral exercise intervention and be randomly assigned an exercise leg. This allows for internal control, non exercise leg. The exercise and control leg will be analysed for significant differences following completion of the intervention.
- Masking
- None (open label)
- Enrolment
- 32 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Loughborough University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Katherine Brooke-Wavell, Loughborough University
- Investigators
- Katherine Brooke-Wavel, PhD, Principal investigator, Loughborough University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03225703
- Sponsor's protocol ID
- R16-P149
- Status last verified
- Jul 2017
- First submitted
- 5 Apr 2017
- Last updated
- 21 Jul 2017
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: There is a plan to have scans available on a public database.
Publications
Du J, Hartley C, Brooke-Wavell K, Paggiosi MA, Walsh JS, Li S, Silberschmidt VV. High-impact exercise stimulated localised adaptation of microarchitecture across distal tibia in postmenopausal women. Osteoporos Int. 2021 May;32(5):907-919. doi: 10.1007/s00198-020-05714-4. Epub 2020 Nov 16.
PubMed 33196852
Study at a glance
From the registry record, last updated by the sponsor on 21 Jul 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women
- ClinicalTrials.gov ID
- NCT03225703
- Acronym / sponsor ID
- R16-P149
- Conditions
- Osteoporosis, Postmenopausal, Osteoarthritis, Knee, BMD
- Keywords
- Exercise, Osteoporosis, Osteoarthritis, MRI, DXA, High Impact, Cartilage, Bone
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 32 participants (estimated)
- Lead sponsor
- Loughborough UniversityUniversity, hospital or other
- Study start
- Jan 2017 (actual)
- Primary completion
- Jun 2018 (estimated)
- Study completion
- Jan 2019 (estimated)
- First posted
- 21 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Osteoarthritis (OA) and osteoporosis (OP) affect large numbers of the population. Around 8 million people in the UK are affected by OA and over 300,000 people present with fragility fractures in the UK each year. High impact exercise has been shown to improve markers of bone health but the effect of this exercise on the cartilage is less well understood. A six month, one leg, exercise program based on hopping will be carried out by a group of post-menopausal women. Post-menopausal women are particularly at risk from OP and the research should give information on the feasibility of this type of exercise program in this age group and the effect on cartilage. Participants will be aged between 55 and 70 (at least five years post menopause) with no conditions that would limit their ability to complete the exercise program.
To assess changes in participants' cartilage and bone properties they will be asked to attend several meetings at Loughborough University. Before and after the exercise program participants will have bone density scans and MRI scans of the knee joint. A subset (n=4) will undergo high resolution bone scans that can demonstrate changes in bone structure. The intervention is a home based exercise programme lasting approximately 10 minutes per day. Initially this will be individualised to each participant with the end goal being daily exercise sessions. The programme will last for six months with supervised sessions offered throughout the trial. Using an intervention affecting just one leg will allow the research team to use the other leg as a control.
The research team hypothesise that in a population of post-menopausal women, a six month, unilateral exercise intervention will improve bone mineral density at the proximal femur with no negative effects on articular cartilage.
Detailed description
The research is a 6 month, intervention study of unilateral (single limb) exercise with the changes in a randomly chosen exercise leg being compared to those in the other (control) leg.
Potential participants (women aged 55-70) will be approached via existing links in the community, at local community centres, through local media, posters and flyers. After initial contact to determine whether they meet the inclusion/exclusion criteria they will be invited to join the study and sent the participant information sheet (PIS). If they then wish to aid in the research they will be invited to a first meeting at Loughborough University.
At the initial meeting the participant can further discuss the project and PIS with the research team. If they fully understand the project and are happy to take part they will be invited to sign the informed consent form. At this stage each participant will be anonymised using a project code. Screening and baseline measurements will then be taken.
Screening questionnaires will be taken following consent to the study. These include a demographic questionnaire, health screen questionnaire, calcium intake questionnaire, physical activity readiness questionnaire (PAR-Q) and bone physical activity questionnaire (BPAQ).
Dual X-ray Absorptiometry (DXA) scans of the whole body, anterior-posterior (AP) spine and dual femur will be taken for each participant to give baseline measurements of bone mineral density.Standard positioning procedures for the measurement being taken will be utilised to allow the calculation of the T-score.
Functional tests will be performed to investigate hopping and balance ability. Unilateral balance will be analysed by measuring postural sway using a force platform. Participants will be asked to balance on one leg for up to 30 seconds. Amplitude of displacement will be calculated, this is the distance between the maximum and minimum centre of pressure (COP) in both directions. COP path length is the total distance travelled and will be calculated and divided by the trial time to give the COP velocity.
Maximal hop height will be measured by recording the vertical displacement of a marker placed on the lumbar spine of each participant whilst conducting a maximal hop. This will be repeated for each leg. The ground reaction force (GRF) of the maximal hop will be recorded using a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform a counter movement, maximal hop using their arms to help with propulsion and ensure maximal hop height. After one or two familiarisation attempts the participant will be asked to complete three maximal hops. Allowing for repeats if they do not land fully on the force platform. The peak GRF recorded from these three attempts will be used in the final analysis.
Ground reaction forces during a set of ten hops, which is the end goal of the exercise programme, will be recorded on a force platform. Participants will be asked to remain still on the platform for 5 seconds to determine body weight. From this position participants will be asked to lift one leg from the platform and perform ten counter movement hops using their arms to help with propulsion if able. At the baseline measurements participants will be asked to perform ten hops to the best of their ability, with a rigid support available for them to lean on
A second appointment will be arranged to acquire baseline MRI scans of each knee joint. This will involve the safety checks, conversation with the radiographers and scan times of up to one hour.
Following the MRI scans the exercise leg will be randomly assigned using opaque envelopes. Each envelope will contain a note saying either 'left leg' or 'right leg'. The envelopes will be split into smaller subgroups of eight for minimisation. This will remove the possibility of the first half of volunteers choosing the same leg and removing the randomisation effect on the second half. Participants will be presented with a training diary and instructions on how to complete the exercise programme over six months. The first day of exercise will be completed with the research team at this appointment and the intervention considered started. This second meeting should last for approximately 90 minutes.
The required exercise lasts for no longer than 10 minutes each session and can be performed at home. The intervention will be personalised to the individual's ability and the frequency of the exercise will steadily increase as the participant improves, until the exercise is completed daily. Regular group sessions at Loughborough University will be offered to all participants. The exercise time will remain at ten minutes but the session will be longer, allowing for discussion and check-ups with participants. These will be weekly sessions for the first two months and then once a month for the remaining time.
Follow up measurements will take place six months after the commencement of the exercise programme. Repeat DXA, MRI and functional outcome tests will be carried out on all participants, following the same protocol as at baseline. Again this will occur over two meetings at Loughborough University.
A subset (n=4) will undergo high resolution bone scans (HR-pQCT) that can demonstrate changes in bone structure. This measurement will be taken at the distal tibia and lasts around three minutes per leg. Measurements will be taken pre and post the six month exercise intervention.
Descriptive statistics will be calculated to give information on mean values and variation (standard deviation) of the cohort. This will include age, height, body mass, BMI and time since last menstruation.
Using Levene's test when comparing the exercise to control leg and Mauchly's test of sphericity to compare from baseline to end of study, the variance of the data will be analysed. Normal distribution will be analysed using Shapiro-Wilks test and visual examination of Q-Q plot. If variance is shown to be homogenous and distribution normal within the population then a repeated measures analysis of variance (RM-ANOVA)will be used to detect any significant differences between leg (exercise versus control, time (baseline versus post-intervention) or leg x time interaction in the outcome variable described previously. If any of the outcome measures do not meet the assumptions to conduct parametric tests i.e. ANOVA then Kruskal-Wallis H test will be used to detect any significant change in differences.
Study design
- Primary purpose
- Basic science
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Participants will complete a unilateral exercise intervention and be randomly assigned an exercise leg. This allows for internal control, non exercise leg. The exercise and control leg will be analysed for significant differences following completion of the intervention.
| Arm | Type | Receives |
|---|---|---|
| Exercise Leg | Active comparator | Behavioral: HoppingLeft or right leg randomly assigned as exercise leg in a unilateral, exercise intervention. This will be a progressive exercise programme with the aim being to complete 50 multidirectional hops completed daily. (Hopping) |
| Non exercise Leg | No intervention | –Randomly assigned non-exercise, control leg. |
Who may qualify
- Ages
- 55 to 70 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Post-menopausal - at least 12 months since last menstruation and/or hysterectomy, oophorectomy or hormonal contraceptive use
Key exclusion criteria (8 listed)
- Existing knee, hip or back injury.
- Any medical conditions or injuries which exclude participation in an exercise intervention e.g. heart conditions, hypertension
- BMI > 30 kg/m2
- Participation in a study involving ionising radiation in the previous 12 months.
- Exercise involving ground reaction forces greater than that of jogging more than once a week.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| HoppingA unilateral, hopping based exercise programme lasting six months. | Behavioural | Exercise Leg |
Primary outcome
Change in T2 Relaxation Time (ms)
Time frame: 6 months (pre and post intervention)
T2 mapping is an indicator of the water content in cartilage, with longer relaxation times a marker of cartilage degeneration
46 secondary outcomes
Change in Femoral neck bone mineral density (g/cm2)
Time frame: 6 months (pre and post intervention)
Change in Femoral neck bone mineral content (g)
Time frame: 6 months (pre and post intervention)
Change in Spine bone mineral density (g/cm2)
Time frame: 6 months (pre and post intervention)
Change in Spine bone mineral content (g)
Time frame: 6 months (pre and post intervention)
Change in Postural sway (mm)
Time frame: 6 months (pre and post intervention)
Change in Maximal hop height (mm)
Time frame: 6 months (pre and post intervention)
Change in Ground Reaction force Maximal Hop (N)
Time frame: 6 months (pre and post intervention)
Change in Ground Reaction force for a set of ten hops (N)
Time frame: 6 months (pre and post intervention)
Change in BMD(D100) (mg HA/cm3)
Time frame: 6 months (pre and post intervention)
Change in Total bone mass (mg)
Time frame: 6 months (pre and post intervention)
Change in BV/TV (%)
Time frame: 6 months (pre and post intervention)
Change in pBV/TV (%)
Time frame: 6 months (pre and post intervention)
Change in rBV/TV (%)
Time frame: 6 months (pre and post intervention)
Change in pBV/rBV (%)
Time frame: 6 months (pre and post intervention)
Change in pBV/BV (%)
Time frame: 6 months (pre and post intervention)
Change in rBV/BV (%)
Time frame: 6 months (pre and post intervention)
Change in Bone surface(BS) (mm2)
Time frame: 6 months (pre and post intervention)
Change in BS/TV (mm-1)
Time frame: 6 months (pre and post intervention)
Change in Tb.Th (mm)
Time frame: 6 months (pre and post intervention)
Change in Tb.Sp (mm)
Time frame: 6 months (pre and post intervention)
Change in Tb.N (mm-1)
Time frame: 6 months (pre and post intervention)
Change in Tb.Pf
Time frame: 6 months (pre and post intervention)
Change in Conn.D (mm-3)
Time frame: 6 months (pre and post intervention)
Change in DA
Time frame: 6 months (pre and post intervention)
Change in τ
Time frame: 6 months (pre and post intervention)
Change in SMI
Time frame: 6 months (pre and post intervention)
Change in BRV (mm3)
Time frame: 6 months (pre and post intervention)
Change in BFV (mm3)
Time frame: 6 months (pre and post intervention)
Change in BRM (mg)
Time frame: 6 months (pre and post intervention)
Change in BFM (mg)
Time frame: 6 months (pre and post intervention)
Change in BRF (%)
Time frame: 6 months (pre and post intervention)
Change in BFF(%)
Time frame: 6 months (pre and post intervention)
Change in BRR(mm3/week)
Time frame: 6 months (pre and post intervention)
Change in BFR(mm3/week)
Time frame: 6 months (pre and post intervention)
Change in Trabecular orientation distribution (Tb.O.D) (angle in degrees)
Time frame: 6 months (pre and post intervention)
Change in Ct.Th(mm)
Time frame: 6 months (pre and post intervention)
Change in B.Po(%)
Time frame: 6 months (pre and post intervention)
Change in Po.Dm(mm)
Time frame: 6 months (pre and post intervention)
Change in Pore volume distribution
Time frame: 6 months (pre and post intervention)
Change in Failure load (N)
Time frame: 6 months (pre and post intervention)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Jul 2017.
- Derived from this study: PubMed 33196852Du J, Hartley C, Brooke-Wavell K, Paggiosi MA, Walsh JS, Li S, Silberschmidt VV. High-impact exercise stimulated localised adaptation of microarchitecture across distal tibia in postmenopausal women. Osteoporos Int. 2021 May;32(5):907-919. doi: 10.1007/s00198-020-05714-4. Epub 2020 Nov 16.
- Individual participant dataSharing planned: Yes. There is a plan to have scans available on a public database.
Related trials for Osteoporosis, Postmenopausal
Active, not recruitingObservational study
The Impact of Osteosarcopenia on Falls, Kinesiophobia, and Quality of Life in Postmenopausal Women
Osteosarcopenia, Sarcopenia
Not yet recruitingPhase 4
Romosozumab and Denosumab Combination Therapy for Osteoporosis
Postmenopausal Osteoporosis
Not yet recruiting
Effects of Sensorimotor Balance Training vs Digitally Augmented Core Stabilization in Women With Osteoporosis
Postmenopausal Osteoporosis
Active, not recruitingPhase 4
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
Osteoporosis, Postmenopausal
RecruitingPhase 4
Combined Anabolic Therapy
Osteoporosis, Postmenopausal, Osteoporosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christopher M Hartley, MSC contact
Katherine Brooke-Wavel, PhD principal investigator
Loughborough University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hopping in people with Osteoporosis, Postmenopausal and Osteoarthritis, Knee, run by Loughborough University at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 21 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Christopher M Hartley, MSC (c.hartley@lboro.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in T2 Relaxation Time (ms) (time frame: 6 months (pre and post intervention)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03225703, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2017.